Cogent Biosciences, Inc. (COGT): Total Assets
$937.61M
As of 2025-12-31
$834.55M
As of 2026-06-30
+46.1%
3-year compound annual growth
+30.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $937.61M | +185.9% | 2026-02-17, Balance as of period end |
| 2024-12-31 | $327.90M | +4.6% | 2026-02-17, Balance as of period end |
| 2023-12-31 | $313.44M | +4.2% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $300.81M | +29.6% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $232.09M | -7.5% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $250.92M | +407.7% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $49.42M | -42.5% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $85.93M | +75.0% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $49.12M | n/a | 2019-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | 2025-12-31 | $937.61M | +185.9% |
| Praxis Precision Medicines, Inc. (PRAX) | 2025-12-31 | $937.91M | +94.1% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $899.42M | +21.1% |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | $1.00B | -5.6% |
| Xencor Inc (XNCR) | 2025-12-31 | $875.50M | -8.0% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $836.65M | -0.5% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $1.06B | +84.1% |
Compare COGT, PRAX, BBIO, VRDN side by side · Screen every company in Pharmaceutical Preparations ↗